Acadia Pharmaceuticals Sees Continued Daybue Momentum in Q3, RBC Says
12:07 PM EST, 11/05/2026 (MT Newswires) -- Acadia Pharmaceuticals (ACAD) reported Q3 results underpi
Related stories
Intercos, EBITDA rettificato Q3 sale dell’8% a 44,5 milioni di euro
Intercos, EBITDA rettificato Q3 sale dell’8% a 44,5 milioni di euro Intercos aumenta l’EBITDA re
L impact | EARNINGS | Nov 05, 2026, 05:15 PM UTC
Intercos Q3 Adjusted EBITDA Rises 8% Year Over Year to EUR 44.5 Million
Intercos Q3 Adjusted EBITDA Rises 8% Year Over Year to EUR 44.5 Million Intercos’ third-quarter
L impact | EARNINGS | Nov 05, 2026, 05:15 PM UTC
INTERCOS - Q3 ADJ EBITDA EUR 44.5 MLN
L impact | EARNINGS | Nov 05, 2026, 05:14 PM UTC
ConocoPhillips Says Turnaround-Related Production Impacts to Be Flat in Q4 vs Q3
M impact | EARNINGS | Nov 05, 2026, 05:12 PM UTC
ConocoPhillips expects Lower 48 production to rise sequentially in Q4
M impact | EARNINGS | Nov 05, 2026, 05:12 PM UTC
Mediobanca Nine-Month Net Profit Rises 13% Year-on-Year to EUR 1.09 Billion
Mediobanca Nine-Month Net Profit Rises 13% Year-on-Year to EUR 1.09 Billion Mediobanca's net pro
L impact | EARNINGS | Nov 05, 2026, 05:12 PM UTC